What did the FDA find wrong with Stanley Brothers Social Enterprises, LLC?

The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.

Are Stanley Brothers Social Enterprises, LLC products safe to use?

Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.

What should I do if I've used Stanley Brothers Social Enterprises, LLC products?

If you have used products from Stanley Brothers Social Enterprises, LLC and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.

Stanley Brothers Social Enterprises, LLC FDA Warning (2017)

Name: Stanley Brothers Social Enterprises, LLC FDA Warning (2017)
Creator: Supplement Safety Data Team
Published: 2026-03-27T01:44:22.855966

Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on October 31, 2017

CRITICAL SEVERITY Los Angeles District Office 2017

Disclaimer: This report is an analysis of a public FDA warning letter. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately.

Executive Summary

The FDA issued a warning letter to Stanley Brothers Social Enterprises, LLC on October 31, 2017 citing regulatory violations. Consumers who have purchased products from this company should exercise caution. The letter was issued by Los Angeles District Office.

Regulatory Violations

Detailed Analysis

False Claims and Regulatory Violations

“My dear ex mother in law has been diagnosed with late stage pancreatic cancer. This is the only thing that gives her relief.”

“[C]urrent studies have reported that CBD is showing promise in how oncologists are looking to treat breast, glioma, Leukemia, thyroid, colon and lung cancer.”

Potential Health Risks

Division of Pharmaceutical Quality Operations IV19701 Fairchild, Irvine, CA 92612-2506Telephone: 949-608-2900Fax: 949-608-4417

Regulatory Context

“The type of dosing that is recommended for clients in partial or complete remission is called ‘maintenance dosing’ and . . . hopefully keeping cancer at bay. Clients using maintenance dosing will likely be using much lower levels of cannabinoid intake than if they were actively trying to fight cancer.”

May 17, 2016 posting – “#Boxing #Concussions #CTE could all benefit from Charlotte’s Web #Hemp extracts #WhyCW . . .”

Key Entities Identified

Stanley Brothers Social Enterprises LLC FDA Warning Letter

Frequently Asked Questions

What did the FDA find wrong with Stanley Brothers Social Enterprises, LLC?: The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
Are Stanley Brothers Social Enterprises, LLC products safe to use?: Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
What should I do if I've used Stanley Brothers Social Enterprises, LLC products?: If you have used products from Stanley Brothers Social Enterprises, LLC and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.

Source Document

This report is based on an official FDA warning letter. The original document is a public record.

View Original FDA Warning Letter

Medical Disclaimer: This report is an analysis of public FDA warning letters. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately. You can report adverse events to the FDA MedWatch program.